PhRMA

NOVEMBER 7, 2022

Concerns about the cost of health care have led to calls for the use of health technology assessments or HTAs by the federal government. This would allow government agencies to make important decisions about patient access to health care based on their determination of the value of new tests and treatments. It’s important to consider the best available information and evidence when making health care decisions.

209

209

Drug Topics

NOVEMBER 7, 2022

Cannabinoids lack the habit-forming mechanism of action found in methadone and buprenorphine, unlocking new potential for the drug.

212

212

PhRMA

NOVEMBER 7, 2022

The United States is facing a crisis of mental health and addiction that has left few Americans and families unimpacted by these illnesses and the devastating consequences that are often associated with them. Mental illness refers to a wide range of mental health conditions that can affect mood, thinking and behavior. These illnesses include substance use disorders and such conditions as depression, anxiety disorders, schizophrenia, bipolar disorder and eating disorders.

176

176

Pharmacy Times

NOVEMBER 7, 2022

A session presenter at the ASCP 2022 Annual Meeting addresses research investigating the value of preventative treatments when patients have a limited life expectancy.

181

181

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

STAT

NOVEMBER 7, 2022

GRAND RAPIDS, Mich. — Doctors are on the frontlines of a political battle raging across the country, as abortion rights are added to the ballot in the first election since the Supreme Court overturned Roe v. Wade. Michigan is at the heart of the struggle. “Doctors fought hard for these rights because we’re sick of watching women die,” Melissa Bayne, an OB-GYN in Fremont, Mich., told the audience at a rally Saturday in Grand Rapids.

Hospitals 145

Hospitals 145

Pharmacy Times

NOVEMBER 7, 2022

A session presenter at the ASCP 2022 Annual Meeting explained how the COVID-19 pandemic significantly magnified the importance of infection prevention and control practices in long-term care.

132

132

Pharmacy Times

NOVEMBER 7, 2022

Leaders must fully understand the benefits of diversity and create an environment in which it thrives to cultivate and inspire the next generation of inclusive leaders.

132

132

pharmaphorum

NOVEMBER 7, 2022

Blood cells grown in a laboratory have been given to people for the first time in a clinical trial being carried out by researchers in the UK, in the hope that plentiful supplies of rare blood groups can be manufactured to order. A team from the universities of Bristol and Cambridge, NHS trusts and NHS Blood and Transplant (NHSBT) have started giving small quantities of the lab-grown red blood cells – a couple of teaspoons full – to two healthy volunteers to see if they are safe.

126

126

Drug Topics

NOVEMBER 7, 2022

Drug Topics® is joined by Joseph Mann, MSN, FNP-C, to discuss the impact of the CDC's streamlined COVID-19 guidance on pharmacy, how pharmacists can prepare for testing demand during the winter respiratory season, and why taking a proactive approach is so important.

98

98

Pharmacy Times

NOVEMBER 7, 2022

Approximately 10% of patients in trial experienced a heart attack, stroke, blocked arteries requiring treatment, or death from cardiovascular disease.

123

123

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Fierce Healthcare

NOVEMBER 7, 2022

UnitedHealth continues to lead the way on insurer profits in Q3. Here's how its competitors fared. pminemyer. Mon, 11/07/2022 - 15:36.

Insurance 133

Insurance 133

Pharmacy Times

NOVEMBER 7, 2022

A session presenter at the ASCP 2022 Annual Meeting explained how patients’ mismanagement of medications for headaches can lead to rebound headaches.

123

123

European Pharmaceutical Review

NOVEMBER 7, 2022

Lab-grown blood cells have been transfused into a second patient in the world’s first-of-a-kind clinical trial , opening up future treatments for blood disorders such as sickle cell if found safe and effective. Stem cells from blood donors were separated and grown to produce modified red blood cells at NHS Blood and Transplant ( NHSBT ) Advanced Therapies Unit in Bristol.

Hospitals 113

Hospitals 113

Pharmacy Times

NOVEMBER 7, 2022

Although fentanyl is potent and often deadly, it is not passively absorbed into the bloodstream.

145

145

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Drug Topics

NOVEMBER 7, 2022

Childhood cancer survivors are high risk of pain and in need of pain relief. Did 2016 guidelines for opioid prescribing change use in this group?

98

98

Pharmacy Times

NOVEMBER 7, 2022

Session presenters at ASCP 2022 Annual Meeting discuss the benefits and disadvantages of apixaban versus warfarin for anticoagulation.

122

122

pharmaphorum

NOVEMBER 7, 2022

In this new segment from pharmaphorum, we collect the most significant hirings, firings, and recruitment stories from across the industry. This month, we highlight new appointments from Lumeris, Lineage Cell Therapeutics, 1910 Genetics, and ADC Therapeutics. . Ben Grabski, Lumeris. Lumeris, a value-based care managed services operator for health systems, has appointed Ben Grabski as chief financial officer.

Pharmaceutical Companies 105

Pharmaceutical Companies Pharmaceutical Companies 105

STAT

NOVEMBER 7, 2022

The morning was crisp and still dark as I sat in my car in the hospital lot, summoning the will to open the door and leave for my shift in the emergency department. Like many frontline providers in early 2021, I felt pancaked by the two pandemic surges — emotionally and morally. Not getting out of the car wasn’t an option. Responsibility to others demanded I get moving.

Hospitals 106

Hospitals 106

Fierce Healthcare

NOVEMBER 7, 2022

Fierce Healthcare Fundraising Tracker—DispatchHealth rakes in $330M; Care.ai banks $27M for ambient intelligence. hlandi. Mon, 11/07/2022 - 17:36.

116

116

Pharmacy Times

NOVEMBER 7, 2022

Intravenous iron reduced the risk of hospitalization for heart failure or cardiovascular death by approximately 20%.

Hospitals 123

Hospitals 123

Fierce Healthcare

NOVEMBER 7, 2022

Walgreens' VillageMD inks $9B deal to buy Summit Health, marking largest physician deal of the year. hlandi. Mon, 11/07/2022 - 11:57.

121

121

STAT

NOVEMBER 7, 2022

Biogen is mulling new options in its search for a CEO after talks with a senior research executive from Johnson & Johnson reached an impasse, STAT has learned. Mathai Mammen, a well-regarded scientist and head of R&D at pharmaceutical giant J&J, had been a frontrunner to become Biogen’s next leader as late as last month. But more recently, talks between Mammen and the company’s board broke down, according to a person familiar with the situation.

102

102

PharmaVoice

NOVEMBER 7, 2022

Using flipMD, organizations can find, vet, connect with and source practicing board-certified physicians from all specialties for contract, project-based or full-time assignments.

98

98

STAT

NOVEMBER 7, 2022

Californians have an opportunity on Tuesday to protect the health of their children by voting yes on Proposition 31 , which would be a vote to prohibit the sale of nearly all flavored tobacco products in the state. It’s a much-needed move, and one that every state in the nation should be taking. Flavored e-cigarettes have addicted a new generation of Americans to nicotine.

98

98

The Checkup by Singlecare

NOVEMBER 7, 2022

According to the American Diabetes Association , 11% of the population has diabetes (also called diabetes mellitus), and another 96 million have prediabetes—making it one of the most common chronic diseases in the U.S. Sadly, it’s also one of the most preventable diseases. Of the two main types of diabetes , Type 2, which develops over years and is usually linked to obesity or a lack of physical activity, accounts for roughly 95% of American cases. .

Assisted Living 98

Assisted Living Compounding Immunization 98

STAT

NOVEMBER 7, 2022

In recent weeks, the National Institutes of Health has begun emailing academic institutions that failed to submit results of clinical trials to a government database, a move that comes shortly after a federal watchdog harshly criticized the agency for lax oversight. More than two dozen institutions have been contacted as of this week, according to the Clinical Trials Registration and Results Reporting Taskforce, a national consortium of academic medical centers, universities, hospitals, and nonp

Hospitals 98

Hospitals 98

Drug Topics

NOVEMBER 7, 2022

Tackling Medicare Part D drug costs takes more than just capping costs.

123

123

STAT

NOVEMBER 7, 2022

Verve Therapeutics said Monday that its experimental gene-editing treatment for a common form of heart disease was placed on clinical hold by the Food and Drug Administration, potentially delaying an ongoing, early-stage clinical trial. The Cambridge, Mass.-based biotech had submitted a request to the FDA in October to allow participants in the U.S. to receive the CRISPR-based treatment, called VERVE-101, as part of its clinical trial program.

FDA 98

FDA 98

The Guardian - Pharmaceutical Industry

NOVEMBER 7, 2022

Exclusive: MHRA grants innovation passport to drug that could prevent women from developing condition A new pill that could prevent pre-eclampsia has become the first pregnancy drug to be fast-tracked for development by the UK’s drug regulator. Scientists at MirZyme Therapeutics, a biopharmaceutical company, believe they have developed a drug that when given to women from 20 weeks of pregnancy could stop them developing the condition.

94

94

STAT

NOVEMBER 7, 2022

The artificial intelligence system is a dream for many doctors: It records their conversations with patients and automatically transcribes the notes into their computer systems. No need to bring a laptop to every patient visit, or spend hours afterward on documentation. But the product, sold by Nuance Communications and its parent, Microsoft, comes with strings attached: To improve its accuracy, health systems sworn to protect privacy must share patients’ most sensitive data with companie

Documentation 98

Documentation Communication Hospitals 98

European Pharmaceutical Review

NOVEMBER 7, 2022

Pfizer Inc. has announced its B-cell maturation antigen (BCMA)-CD3-targeted bispecific antibody (BsAb) elranatamab for relapsed or refractory multiple myeloma (RRMM) has received Breakthrough Therapy Designation from the US Food and Drug Administration (FDA). The designation is based on six months of follow-up data from a Phase II study ( NCT04649359 ) evaluating the safety and efficacy of a 76mg weekly (QW) dose of elranatamab, which showed overall response rate (ORR) was 61 percent. .

FDA 95

FDA 95

STAT

NOVEMBER 7, 2022

Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating, because that oh-so familiar routine of deadlines, online meetings, and phone calls has predictably returned. But what can you do? The world, such as it is, keeps spinning. So time to give it a nudge in a better direction with a carefully brewed cup of stimulation.

98

98

Outsourcing Pharma

NOVEMBER 7, 2022

Charles River Laboratoriesâ growing gene therapy manufacturing capabilities have landed it a deal with the eye disease biotech Nanoscope Therapeutics.

98

98

Fierce Healthcare

NOVEMBER 7, 2022

'Well-intentioned, poorly executed waste': How tech companies aim to reduce billions in wasteful spending. agliadkovskaya. Mon, 11/07/2022 - 23:29.

98

98